Evaluating the Future Trajectory of Patient Access and Pricing Strategies in the China CAR T Cell Therapy Market Forecast
  The long-term success and accessibility of revolutionary treatments like CAR T-cell therapy in China are critically tied to the development of sustainable reimbursement and pricing models. Currently, the high cost of these therapies restricts access primarily to patients in large, affluent cities or those with robust private insurance. However, the government's push for a domestically...
0 Commentaires 0 Parts 18 Vue 0 Aperçu
Commandité